Jan Mattsson
10Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Jun 19, 2003 → Feb 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10941127B2 | Benzothiadiazepine compounds and their use as bile acid modulators | Human Necessities | 21 | Active |
| US10975045B2 | Benzothiazepine compounds and their use as bile acid modulators | Human Necessities | 18 | Active |
| US10793534B2 | Benzothia(di)azepine compounds and their use as bile acid modulators | Chemistry; Metallurgy | 16 | Active |
| US11306064B2 | Benzothia(di)azepine compounds and their use as bile acid modulators | Chemistry; Metallurgy | 12 | Active |
| US11773071B2 | Benzothiazepine compounds and their use as bile acid modulators | Human Necessities | 9 | Active |
| US11603359B2 | Benzothiadiazepine compounds and their use as bile acid modulators | Human Necessities | 8 | Active |
| US11583539B2 | Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors | Human Necessities | 8 | Active |
| US12187690B2 | Benzothiadiazepine compounds and their use as bile acid modulators | Human Necessities | 1 | Active |
| US7964609B2 | Use of mGluR5 antagonists for the treatment of gerd | Human Necessities | 0 | Expired |
| US7718686B2 | Imidazole variants as modulators of GABA receptor for the treatment of GI disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.